Ambalal Sarabhai Enterprises Limited Peer Comparison
AMBALALSA · Healthcare · Current price ₹37.75
Peers tracked
11
Ambalal Sarabhai Enterprises Limited P/E
26.4x
Sector
Healthcare
Ambalal Sarabhai Enterprises Limited vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,758.8 | 36.9x | 4,22,273 |
| Divi's Laboratories Limited | ₹9,144.5 | 85.4x | 2,44,762 |
| Torrent Pharmaceuticals Limited | ₹4,558.9 | 86.9x | 1,73,442 |
| Zydus Lifesciences Limited | ₹1,123 | 24.3x | 1,12,149 |
| Laurus Labs Limited | ₹2,060.1 | 95.9x | 1,11,250 |
| Cipla Limited | ₹1,325.1 | 33.2x | 1,07,043 |
| Dr. Reddy's Laboratories Limited | ₹1,233 | 29.9x | 1,02,815 |
| Aurobindo Pharma Limited | ₹1,666.9 | 25.9x | 95,513 |
| Mankind Pharma Limited | ₹2,275.5 | 44.9x | 93,968 |
| Lupin Limited | ₹1,961.6 | 17.1x | 89,437 |
| Ambalal Sarabhai Enterprises Limited | ₹37.79 | 13.8x | 292 |
Ambalal Sarabhai Enterprises Limited versus its peers
Ambalal Sarabhai Enterprises Limited operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 26.4x may be cheap in one industry and expensive in another.
More on Ambalal Sarabhai Enterprises Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.